These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients. Lilleri D, Piccinini G, Genini E, Comolli G, Chiesa A, Tordato F, Sotgiu G, Parisi A, Baldanti F, Revello MG, Gerna G. J Clin Virol; 2004 Apr; 29(4):297-307. PubMed ID: 15018859 [Abstract] [Full Text] [Related]
45. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype. Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group. J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038 [Abstract] [Full Text] [Related]
46. Acute onset bilateral cataracts in an infant with vertically transmitted HIV with CMV retinitis despite treatment. Tong L, Hodgkins P, Taylor D. Eye (Lond); 1998 Dec 01; 12 ( Pt 1)():150. PubMed ID: 9614536 [No Abstract] [Full Text] [Related]
47. An epidemic of blindness: a consequence of improved HIV care? Guex-Crosier Y, Telenti A. Bull World Health Organ; 2001 Dec 01; 79(3):181. PubMed ID: 11285660 [No Abstract] [Full Text] [Related]
48. Combination HIV therapy and opportunistic infections of the eye in people with AIDS. Ash S. Br J Ophthalmol; 1998 Sep 01; 82(9):981-2. PubMed ID: 9893581 [No Abstract] [Full Text] [Related]
49. [Ophthalmic manifestations in AIDS]. Nagata Y, Fujino Y, Mochizuki M. Nihon Rinsho; 1993 Sep 01; 51 Suppl():413-6. PubMed ID: 8271411 [No Abstract] [Full Text] [Related]
50. HIV and family living. Preventing the spread of HIV and other diseases. Sax P, Weinberger H. AIDS Clin Care; 1995 Oct 01; 7(10):83-4. PubMed ID: 11362833 [Abstract] [Full Text] [Related]
51. HIV-associated CMV retinitis occurring in the setting of a high CD4+ count: what about AIDS definitions? Angus BJ, Green ST, McKinlay JJ, McMenamin J, Walker E. Int J STD AIDS; 1994 Oct 01; 5(1):71-2. PubMed ID: 7908228 [No Abstract] [Full Text] [Related]
52. The management of cytomegalovirus retinitis in AIDS. Dhillon B. Br J Ophthalmol; 1994 Jan 01; 78(1):66-9. PubMed ID: 8110704 [No Abstract] [Full Text] [Related]
53. Stopping anti-CMV therapy may be safe option for some HIV patients. Am J Health Syst Pharm; 2000 Jan 01; 57(1):21. PubMed ID: 10630552 [No Abstract] [Full Text] [Related]
54. PCR could help screen patients for CMV treatment. AIDS Alert; 1997 Aug 01; 12(8):94-5. PubMed ID: 11364476 [Abstract] [Full Text] [Related]
55. Protease inhibitors linked to drop in CMV retinitis. AIDS Alert; 1997 Aug 01; 12(8):92-4. PubMed ID: 11364475 [Abstract] [Full Text] [Related]
56. On the edge: measuring CMV viral load. McGuire S. Posit Aware; 1997 Aug 01; 8(1):16-7. PubMed ID: 11364091 [Abstract] [Full Text] [Related]
57. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA. J Infect Dis; 2002 Jul 01; 186(1):114-7. PubMed ID: 12089671 [Abstract] [Full Text] [Related]
58. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Kedhar SR, Jabs DA. Herpes; 2007 Dec 01; 14(3):66-71. PubMed ID: 18371289 [Abstract] [Full Text] [Related]
59. PCR could help screen patients for CMV treatment. AIDS Alert; 1997 Aug 01; 12(8):94-5. PubMed ID: 11364476 [Abstract] [Full Text] [Related]